Canton Strategic Holdings, Inc. (CNTN) stock: key figures, P/E, revenue and dividend
Financials · United States · ISIN US4327053090
Canton Strategic Holdings, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Operating income | -20.11 m USD |
| EBIT | -42.08 m USD |
| Net income | -35.92 m USD |
| Diluted EPS – continuing operations | -1.12 USD |
Full history since 2019, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Canton Strategic Holdings, Inc.
Canton Strategic Holdings, Inc. engages in the institutional blockchain adoption and digitization of financial markets in the United States. It operates in two segments, Digital Asset Treasury and Clinical Stage Bio-technology. The company is involved in the operation of Canton Coin-centric digital asset treasury strategies, including validator operations and network participation; application support and strategic investments; collaboration and ecosystem advancement; capital raising and treasury expansion; token management - locking, lending, and options; Canton Foundation; and governance and risk management. It also researches and develops GV104, a buccal film formulation of nalmefene for the treatment of respiratory depression and prophylactic protection against synthetic opioid exposure in military and first responders; and GV023, an oral anti-tumor necrosis factor-alpha monoclonal antibody that addresses critical limitation of IV gold standard for the treatment of repeated intravenous infusions. The company was formerly known as Tharimmune, Inc. and changed its name to Canton Strategic Holdings, Inc. in February 2026. Canton Strategic Holdings, Inc. was incorporated in 2017 and is headquartered in Red Bank, New Jersey.
More stocks
- Wafangdian Bearing Co Ltd (200706.SZ)
- Mycenax Biotech (4726.TWO)
- KNJ Co. Ltd (272110.KQ)
- Hannong Chem (011500.KS)
- Taita Chemical Co Ltd (1309.TW)
- Exascale Labs Holdings Inc. Class A Common Stock (XLAB)
- Promate Solutions (6577.TWO)
- Partron Co. Ltd (091700.KQ)
- TriLinc Global Impact Fund LLC (TRLC)
- Paik Kwang Ind (001340.KS)
- AMBEST GROUP BERHAD (0391.KL)
- CMSC, Inc. (7707.TWO)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.